Metro AJC DETROIT PRESENTS AN EVENING WITH Elizabeth Bettina t Ni-01.t) s . rt,ittc, AND (,I 11 ■41N% rtIF. PEA ■ 1•1.1: OF Ursula Korn-Selig 11 NIA DFFIF.1% rlle "4.1s. 111)11,114.411 ,+ TtIC 11c)1.1.11. NI SI Women With Advanced Breast Cancer Sought "It Happened in Italy" Untold stories of how the people of Italy defied the Horrors of the Holocaust Monday, November 30, 2009 7:30 - 9:00 PM S Holocaust Memorial Center Cosponsored by: Holocaust Memorial Center, Archdiocese of Detroit, JCC, and the Italian Consulate in Detroit $20 Couvert, includes dessert reception RSVP to detroit@ajc.org or 248.646.7686 ‘111110 American Jewish Committee 1551950 "DESIGNS IN DECORATOR WOOD & LAMINATES, LTD. It Doesn't Have To Cost ortunemOnly Look Like it! t. Joseph Mercy Oakland (SJMO) is seeking women with triple negative breast cancer to participate in a clinical trial through Saint Joseph Mercy Health System at St. Joseph Mercy Oakland, 44405 Woodward Ave., Pontiac. St. Joseph Mercy Ann Arbor also is participating in the trial. The trial is to test a novel drug in the treatment of an aggressive form of breast cancer that has spread beyond the breast. The hospitals seek women with advanced breast cancer to test an experimental targeted drug, BSI 201. When used with traditional chemo- therapy that damages the cancer cell's DNA, the trial drug selectively blocks a cancer cell's ability to repair itself and causes the cancer cell to die. To participate in the trial, patients must have metastatic triple negative breast cancer, have completed no more than two rounds of chemotherapy treatment and have disease that is mea- surable on an imaging study. Involved in the trial is SJMO's medi- cal director of oncology services, Dr. Judie Goodman. For more information, call the Michigan Cancer Research Consortium, (877) 590-5995. I 1 Study Investigating Alzheimer Treatment T Complete kitchen and bathroom remodeling as well as furniture design and installations including granite, wood and other materials. Lois Huron Allied Member ASID 248.851.6989 Send your college student news from home! College kids love news from home - the JN will help keep them in touch with everything that is happening while they are away! he Ann Arbor-based Mood & Memory Clinic of Michigan has begun enrolling patients with Alzheimer's disease in the CONCERT study, a new clinical trial that will test the efficacy of the inves- tigational drug dimebon (latrepirdine) in patients currently taking Aricept (donepezil HCI tablets), an Alzheimer's disease medication worldwide. "Alzheimer's is a complex disease and while current medications address symptoms for some patients, the dis- ease often requires combination ther- apy to maximize clinical benefit," said Stephen Aronson, M.D., CONCERT investigator. "CONCERT is an impor- tant study because dimebon is thought to work differently than current medi- cations and this study will evaluate whether adding it to one of the most commonly used Alzheimer's medi- cations will provide more effective symptomatic treatment to patients." While a cure is still many years away, treatments that provide lasting effects, more complete symptomatic benefits or slow disease progression would be meaningful advances for patients and caregivers; for this reason there is an urgent need for patients to participate in clinical trials to help advance the understanding of how Alzheimer's dis- ease can be better treated. According to estimates from the Alzheimer's Association, 5.3 million people in the United States are liv- ing with Alzheimer's, a devastating disease that hinders a patient's ability to remember, learn, perform daily activities and relate to others. As the baby boomer population ages, the incidence of Alzheimer's is expected to increase dramatically. CONCERT is an international, ran- domized, placebo-controlled study that will enroll 1,050 patients with mild-to- moderate Alzheimer's disease at 100 sites in the United States, Australia, New Zealand and Western Europe. For more information on eligibility and enrollment, patients and caregiv- ers can call Ellen Near at (734) 973- 9700 or the CONCERT study hotline toll-free at (877) 888-6386, or visit www.concertstudy.com. Fl Call us today and we'll take care of the rest New Book On ADHD 800.875.6621 - S E itkedigAizZeiT7. $20 per year *10 months • In-state only • Call for out of state special rates Visit theJEWISHNEWS.com 18 November 12 • 2009 JN Dr. Joel Young of West Bloomfield, medical director and founder of the Rochester Center for Behavioral Medicine, has released his second book on Adult Attention Deficit/ Hyperactivity disorder. Contemporary Guide to Adult ADHD, now in publication by Handbooks in Healthcare, offers a comprehensive look at the diagnosis. The book is available at hhcbooks. corn and amazon.com .